IGF-2 Common Research Questions — Research Reference
Insulin-like growth factor 2 (IGF-2) is a fundamental peptide hormone meticulously studied for its multifaceted roles in cellular growth, differentiation, and metabolism, primarily through its interactions with insulin-like growth factor 1 receptor (IGF1R) and, in certain contexts, the insulin receptor. Researchers frequently explore IGF-2’s complex signaling cascades and regulatory mechanisms across various biological systems.
This comprehensive reference addresses IGF-2 common research questions, drawing upon numerous peer-reviewed publications indexed in PubMed and the several registered studies observed on ClinicalTrials.gov, all within a strictly research-use-only framework. Understanding IGF-2’s intricate biochemistry and biological actions is paramount for advancing our knowledge in fundamental cell biology and developmental processes.
IGF-2: Fundamental Biochemistry and Structural Properties in Research
Insulin-like Growth Factor 2 (IGF-2) stands as a pivotal peptide in numerous biological research contexts, primarily recognized for its critical role in growth and development. Classified as an insulin-like growth factor, IGF-2 is a single-chain polypeptide composed of 67 amino acid residues in its mature human form. Its molecular architecture exhibits remarkable conservation across species, underscoring its fundamental biological significance. The peptide’s structure is stabilized by three disulfide bonds, which are crucial for maintaining its tertiary conformation and receptor binding affinity. These bonds link specific cysteine residues, forming a compact and stable domain that facilitates interaction with its cognate receptors and IGF-binding proteins (IGFBPs), thereby modulating its bioavailability and activity in research models. Understanding this intricate disulfide bond arrangement is essential for designing experiments involving recombinant IGF-2 and analyzing its functional integrity.
Peptide Architecture and Homology
The primary sequence of IGF-2 reveals a strong evolutionary relationship with insulin, reflecting a common ancestral gene. This homology is particularly evident in the arrangement of cysteine residues and certain conserved amino acid motifs, which contribute to the shared structural fold. Despite this similarity, IGF-2 possesses distinct functional characteristics, primarily mediated by its differential receptor binding profile. Unlike insulin, which primarily targets the insulin receptor (IR), IGF-2 exhibits high affinity for the IGF-1 receptor (IGF1R), and also interacts with the IGF-2 receptor (IGF2R, also known as the mannose 6-phosphate receptor) which is crucial for its clearance, rather than signal transduction. Researchers often leverage this structural and functional divergence to design studies that specifically investigate IGF-2’s unique contributions to cellular processes, often employing engineered peptides or antagonists to dissect these intricate pathways. Further insights into peptide structure and function can be found in general resources like What Are Research Peptides?.
Isoforms and Post-Translational Modifications
The IGF-2 gene gives rise to several mRNA transcripts through alternative splicing and the use of multiple promoters, resulting in precursor proteins that undergo complex post-translational modifications. The pro-IGF-2 precursor is proteolytically cleaved to yield the mature 67-amino acid peptide. Research has identified various isoforms, though the mature form is the most widely studied. Additionally, IGF-2 can undergo other modifications, such as glycosylation, which may influence its stability, half-life, and interaction with binding proteins and receptors in specific microenvironments. The precise biological implications of these modifications are an active area of research, particularly in understanding tissue-specific IGF-2 activity and bioavailability. Researchers developing cell culture models or performing in vivo studies must consider the potential presence and effects of different isoforms and modifications to accurately interpret their experimental outcomes.
Biophysical Characteristics Relevant to Research
The biophysical properties of IGF-2, including its solubility, stability, and propensity for aggregation, are critical considerations for its experimental use. As a relatively small, globular protein, IGF-2 is generally soluble in aqueous solutions. However, its stability can be influenced by factors such as pH, temperature, and the presence of proteases. The interaction of IGF-2 with IGFBPs significantly extends its half-life in biological fluids, preventing rapid degradation and modulating its availability to receptors. In research settings, careful handling and storage protocols are paramount to maintain the peptide’s integrity and biological activity, ensuring reliable and reproducible experimental results. Recombinant IGF-2 used in studies often undergoes rigorous quality control to confirm its structural integrity and functional efficacy, which is vital for the consistency of long-term research projects. This attention to detail in handling and characterization is fundamental for any research utilizing peptide agents.
Mechanism of Action: Receptor Interactions and Intracellular Signaling Pathways in IGF-2 Research
The mechanism of action for Insulin-like Growth Factor 2 (IGF-2) is primarily initiated through its binding to specific cell surface receptors, triggering a cascade of intracellular signaling events. As an insulin-like growth factor, IGF-2 exhibits a complex receptor binding profile, differentiating its biological effects from those of insulin and IGF-1. The most critical mediator of IGF-2’s growth-promoting and anti-apoptotic effects is the IGF-1 receptor (IGF1R), a tyrosine kinase receptor with significant structural homology to the insulin receptor (IR). Upon IGF-2 binding, IGF1R undergoes autophosphorylation of its intracellular tyrosine residues, creating docking sites for various adaptor proteins. This initial event is the linchpin for activating downstream signaling pathways that ultimately influence cellular proliferation, differentiation, and survival, making IGF1R a central focus in growth-signaling research involving IGF-2.
Primary Receptor Binding and Activation
IGF-2 binds to IGF1R with high affinity, comparable to that of IGF-1, leading to the activation of its intrinsic tyrosine kinase domain. This binding event induces conformational changes in the receptor, leading to the trans-phosphorylation of specific tyrosine residues within the receptor’s β-subunits. These phosphorylated tyrosines serve as crucial binding sites for intracellular signaling molecules containing Src homology 2 (SH2) domains, such as Insulin Receptor Substrate (IRS) proteins (IRS-1, IRS-2) and Shc adaptor proteins. The recruitment and phosphorylation of these adaptor proteins are critical steps that propagate the signal from the cell surface into the cytoplasm. While IGF-2 can also bind to the insulin receptor (IR) with a lower affinity, its primary growth-promoting actions are predominantly mediated through IGF1R, establishing the IGF1R as the primary transducer of IGF-2’s anabolic and mitogenic signals in numerous experimental models.
The Role of IGF2R in IGF-2 Clearance
A unique aspect of IGF-2’s mechanism is its interaction with the IGF-2 receptor (IGF2R), also known as the mannose 6-phosphate receptor (M6P/IGF2R). This receptor binds IGF-2 with high affinity, but critically, it lacks an intracellular tyrosine kinase domain. Instead of initiating signaling, IGF2R functions primarily as a clearance receptor. Upon binding IGF-2, the IGF2R-IGF-2 complex is internalized via clathrin-mediated endocytosis and delivered to lysosomes for degradation. This process effectively removes IGF-2 from the extracellular space, thereby regulating its bioavailability and preventing overstimulation of IGF1R. Research suggests that IGF2R plays a crucial role in modulating the local concentrations of IGF-2, impacting its biological effects, particularly during embryonic development and in contexts where precise control over growth factor signaling is essential. Genetic ablation or pharmacological inhibition of IGF2R can lead to increased IGF-2 levels and enhanced IGF1R signaling, highlighting its important regulatory function in research settings. Further exploration into the detailed mechanism of IGF-2 can be found at IGF-2 Mechanism of Action.
Key Intracellular Signaling Cascades
The activation of IGF1R by IGF-2 primarily converges on two major intracellular signaling pathways: the Phosphatidylinositol 3-kinase (PI3K)/Akt pathway and the Mitogen-Activated Protein Kinase (MAPK)/ERK pathway. Following the phosphorylation of IRS proteins, PI3K is recruited and activated, leading to the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3). PIP3 then serves as a docking site for Akt (Protein Kinase B), which, once phosphorylated, promotes cell survival, inhibits apoptosis, and stimulates protein synthesis and glucose uptake. Concurrently, activation of the MAPK/ERK pathway, often initiated through Shc-Grb2-SOS complex formation and subsequent Ras activation, leads to a cascade of phosphorylation events culminating in the activation of ERK1/2. Activated ERK1/2 translocates to the nucleus, regulating the expression of genes involved in cellular proliferation and differentiation. The precise balance and cross-talk between these pathways are critical in determining the specific cellular response to IGF-2, providing rich avenues for investigation in various research models focused on growth and development.
Investigating IGF-2 in Developmental Biology and Organogenesis Research Models
Insulin-like Growth Factor 2 (IGF-2) is undeniably one of the most thoroughly investigated growth factors in the realm of developmental biology. Its ubiquitous expression during embryogenesis and its potent mitogenic and anti-apoptotic properties underscore its indispensable role in orchestrating normal fetal growth and development across numerous mammalian species. Research in this area has leveraged a variety of model systems, from genetically modified rodents to advanced organoid cultures, to dissect the precise mechanisms by which IGF-2 influences early developmental events. Studies have consistently demonstrated that perturbations in IGF-2 expression or signaling pathways lead to significant developmental abnormalities, including growth restriction or overgrowth phenotypes, providing compelling evidence of its critical involvement from conception through birth. The intricate regulation of IGF-2’s expression, particularly its genomic imprinting, further highlights its unique biological control over developmental trajectories.
IGF-2 in Embryonic and Fetal Growth
Throughout embryonic and fetal development, IGF-2 acts as a primary determinant of somatic growth. Studies using knockout mouse models, where the IGF-2 gene is deleted, invariably result in significant prenatal and postnatal growth retardation, underscoring its absolute requirement for achieving normal size and weight. Conversely, overexpression of IGF-2 can lead to fetal overgrowth. This tightly regulated dosage sensitivity points to IGF-2’s role as a critical rheostat for growth. Its influence extends to coordinating cellular proliferation, nutrient allocation, and overall tissue accretion during periods of rapid expansion. Researchers utilize these models to understand how various environmental factors, maternal nutrition, and genetic predispositions can modulate IGF-2 levels and activity, thereby impacting fetal growth trajectories and potentially programming long-term health outcomes. These investigations are crucial for unraveling the fundamental biological principles governing growth.
Role in Placental Development and Nutrient Partitioning
Beyond its direct effects on the embryo, IGF-2 plays a pivotal role in the development and function of the placenta, the vital organ connecting the mother and fetus. The placenta expresses high levels of IGF-2, which is critical for trophoblast proliferation, invasion, and vascularization – processes essential for establishing an efficient feto-maternal interface. Research indicates that IGF-2 produced by the placenta can act locally, stimulating placental growth and ensuring adequate nutrient and oxygen transfer to the fetus. It also contributes to systemic fetal circulation, directly influencing fetal growth. Disturbances in placental IGF-2 expression or signaling are frequently associated with complications such as intrauterine growth restriction (IUGR) or preeclampsia, emphasizing its role in nutrient partitioning and optimal placental function. Understanding this interplay is vital for identifying potential markers and intervention strategies in research aiming to support healthy pregnancy outcomes.
Organ-Specific Developmental Contributions
IGF-2’s developmental influence is not uniform but exhibits tissue-specific roles across various organ systems during organogenesis. For instance, in musculoskeletal development, IGF-2 promotes myoblast proliferation and differentiation, contributing to muscle mass accretion, and stimulates chondrocyte growth and osteoblast activity, impacting skeletal formation. In neurogenesis, IGF-2 acts as a potent neurotrophic factor, supporting neuronal survival, migration, and differentiation, particularly in the developing brain. It also plays a role in the development of other organs, including the heart, liver, and kidney, promoting cellular expansion and maturation. Research employing conditional knockout models or overexpression strategies in specific tissues has been instrumental in dissecting these nuanced, organ-specific functions of IGF-2, providing a detailed map of its developmental contributions. These studies often shed light on the complex interplay between IGF-2 and other growth factors and signaling pathways that orchestrate the precise patterning and functional maturation of diverse tissues.
IGF-2’s Role in Cellular Proliferation, Differentiation, and Apoptosis Research
Insulin-like Growth Factor 2 (IGF-2) is a potent mediator of fundamental cellular processes, profoundly influencing cellular proliferation, differentiation, and the regulation of apoptosis across a wide array of cell types and tissue contexts. Its capacity to stimulate cell division and survival is a cornerstone of its role in embryonic development and tissue maintenance, making it a critical subject in cell biology research. The mitogenic effects of IGF-2 are primarily exerted through the activation of the IGF-1 receptor (IGF1R), which subsequently engages downstream signaling cascades such as the PI3K/Akt and MAPK/ERK pathways. These pathways culminate in changes in gene expression and protein activity that promote cell cycle progression, inhibit programmed cell death, and guide cells toward specific developmental fates. Investigations into these mechanisms are crucial for understanding both normal physiological processes and pathological states where growth dysregulation is a hallmark.
Stimulating Cellular Proliferation and Survival
A central tenet of IGF-2 research is its robust ability to stimulate cellular proliferation. By activating IGF1R, IGF-2 triggers signals that drive cells through the G1/S phase transition of the cell cycle, thereby increasing cell numbers. This proliferative effect is evident in various cell lines and primary cultures, including fibroblasts, muscle cells, and neuronal progenitors, making IGF-2 a common additive in cell culture media for promoting growth. Beyond mere proliferation, IGF-2 also exhibits strong anti-apoptotic properties. It activates the PI3K/Akt pathway, leading to the phosphorylation and inactivation of pro-apoptotic proteins (e.g., Bad) and the activation of anti-apoptotic proteins (e.g., Bcl-2 family members). This dual action—promoting cell growth and preventing cell death—confers a powerful survival advantage to cells exposed to IGF-2, an effect frequently studied in contexts ranging from tissue repair to the investigation of cellular dysregulation.
Modulating Cellular Differentiation
While often associated with proliferation, IGF-2 also plays a sophisticated role in modulating cellular differentiation. Its influence can be lineage-specific and context-dependent, sometimes promoting differentiation and at other times maintaining cells in an undifferentiated, proliferative state. For instance, in skeletal muscle development (myogenesis), IGF-2 promotes myoblast proliferation, but as cells differentiate into myotubes, IGF-2 can continue to support their growth and maturation. In neurogenesis, IGF-2 is crucial for the proliferation of neural stem cells and also influences the differentiation of various neuronal subtypes. The intricate balance between proliferation and differentiation is often determined by the concentration of IGF-2, the presence of other growth factors, and the specific receptor repertoire expressed by the cells. Researchers frequently use IGF-2 in differentiation protocols for stem cells or progenitor cells to guide their development into specific cell lineages, providing valuable tools for regenerative medicine research models.
Implications for Apoptosis Regulation
The anti-apoptotic actions of IGF-2 are profoundly important, extending its influence beyond merely promoting growth to actively protecting cells from various apoptotic stimuli. By enhancing cell survival, IGF-2 contributes to tissue homeostasis and integrity, particularly in tissues undergoing high turnover or stress. The molecular mechanisms involve the activation of Akt, which phosphorylates and inactivates components of the intrinsic apoptotic pathway, such as caspase-9 and various forkhead transcription factors that regulate pro-apoptotic gene expression. This protective effect has significant implications in numerous research models exploring cellular resilience and disease mechanisms. For example, in studies of tissue injury or neurodegeneration, IGF-2 is often investigated for its potential to mitigate cell loss. However, this anti-apoptotic potency also necessitates careful consideration in research contexts involving uncontrolled cell growth, highlighting the complex and context-dependent nature of IGF-2’s biological functions.
Exploring IGF-2 and Metabolic Regulation in Preclinical Studies
The intricate relationship between Insulin-like Growth Factor 2 (IGF-2) and metabolic regulation is a rapidly expanding area of preclinical research. While traditionally recognized for its profound impact on growth and development, accumulating evidence highlights IGF-2’s significant, albeit complex, contributions to glucose homeostasis, lipid metabolism, and overall energy balance. This metabolic dimension of IGF-2’s biology stems from its structural homology to insulin and its ability to interact with the insulin receptor (IR) and hybrid receptors (IGF1R/IR), alongside its primary receptor, IGF1R. Preclinical studies, predominantly utilizing rodent models, have been instrumental in dissecting these roles, offering valuable insights into how IGF-2 signaling pathways modulate key metabolic processes in various tissues such, as the liver, skeletal muscle, and adipose tissue. These investigations are critical for understanding fundamental metabolic physiology and for identifying novel research avenues related to metabolic dysregulation.
Impact on Glucose Homeostasis
Research indicates that IGF-2 can influence glucose metabolism, albeit with nuances compared to insulin. In several preclinical models, IGF-2 has been shown to stimulate glucose uptake in peripheral tissues, particularly skeletal muscle, and to promote glycogen synthesis in both muscle and liver. These effects are often mediated through its interaction with the IGF1R, which can signal via the PI3K/Akt pathway, a central mediator of insulin’s metabolic actions. Furthermore, IGF-2’s affinity for the insulin receptor (IR) and hybrid receptors suggests that it can directly, or indirectly, contribute to glucose disposal by activating similar downstream signaling pathways to insulin. Studies have explored the effects of both systemic and localized IGF-2 overexpression or deficiency on parameters such as blood glucose levels, insulin sensitivity, and glucose tolerance tests in various research animal models, revealing context-dependent metabolic outcomes that warrant further detailed investigation into its precise role in glucose regulation.
Influence on Lipid Metabolism
The role of IGF-2 in lipid metabolism is another significant area of preclinical study. Research has shown that IGF-2 can influence adipogenesis—the development of adipose tissue—and modulate lipid synthesis and breakdown. In some models, IGF-2 has been observed to promote the differentiation of pre-adipocytes into mature adipocytes, potentially impacting fat mass and distribution. Conversely, other studies suggest a role for IGF-2 in maintaining lean body mass and reducing fat accumulation, particularly in conditions of overnutrition. Its interaction with adipose tissue cells can regulate processes like lipolysis and lipogenesis, impacting the availability of free fatty acids for energy production or storage. The precise mechanisms through which IGF-2 exerts these effects on lipid metabolism are still under active investigation, involving complex interplay with insulin signaling, inflammatory pathways, and transcriptional regulators of lipid-handling genes in various adipose depots. These studies highlight IGF-2 as a multifactorial modulator of energy substrate utilization.
Interactions with Insulin Signaling in Metabolic Research
A key aspect of IGF-2’s metabolic function lies in its intricate cross-talk with insulin signaling pathways. Given the structural homology between IGF-1R and IR, and IGF-2’s ability to bind to both, there is significant overlap and potential for synergy or competition at the receptor level. In metabolic tissues, IGF-2 can activate PI3K/Akt signaling, a pathway crucial for insulin’s actions in glucose and lipid metabolism. Preclinical studies have explored how varying levels of IGF-2, or modulation of its receptor interactions, can impact insulin sensitivity and overall metabolic health in models of insulin resistance or obesity. For example, some research suggests that IGF-2 might compensate for impaired insulin signaling in certain contexts, while in others, it could contribute to receptor desensitization. Understanding this delicate balance and the precise nature of IGF-2’s interaction with the broader insulin signaling network is paramount for deciphering its full metabolic impact and for exploring its potential in advanced preclinical studies focused on metabolic disease mechanisms.
The IGF-2/IGF1R Axis and Cross-Talk with Insulin Receptors: Research Perspectives
The IGF-2/IGF1R axis represents a central signaling pathway critical for growth, development, and cellular function, which has been the subject of numerous studies in growth-signaling research. IGF-2 exerts its primary biological effects by binding to and activating the Insulin-like Growth Factor 1 Receptor (IGF1R), a transmembrane tyrosine kinase receptor. This interaction initiates a cascade of intracellular events fundamental for cell proliferation, differentiation, and survival. However, the complexity of IGF-2 signaling extends beyond a simple ligand-receptor interaction due to the significant structural homology between IGF1R and the insulin receptor (IR), and the existence of hybrid receptors formed by IGF1R and IR heterodimerization. This intricate receptor landscape allows for significant cross-talk and functional redundancy, as well as distinct signaling outcomes, depending on the specific receptor activated and the cellular context. Dissecting these receptor interactions is a key research objective for understanding the nuanced biological roles of IGF-2.
Specificity and Affinity for IGF1R
IGF-2 binds to IGF1R with high affinity, comparable to that of IGF-1, making IGF1R the predominant mediator of its mitogenic and anti-apoptotic actions. The interaction triggers autophosphorylation of the IGF1R, leading to the recruitment and activation of adaptor proteins like IRS-1/2 and Shc, which subsequently activate downstream pathways such as PI3K/Akt and MAPK/ERK. The specificity of IGF-2 for IGF1R is crucial in many developmental processes, where precise control over cell growth and differentiation is required. Research has focused on developing selective IGF1R inhibitors or IGF-2 variants with altered receptor affinities to delineate the specific contributions of the IGF-2/IGF1R axis in various biological models. These studies often compare the effects of IGF-2 with IGF-1, which also signals through IGF1R, to elucidate shared and unique signaling attributes, further refining our understanding of growth factor biology.
Formation and Function of Hybrid Receptors
A significant layer of complexity in IGF-2 signaling arises from the formation of hybrid receptors, which are heterodimers composed of one half-receptor of IGF1R and one half-receptor of IR (αβ-IR/αβ-IGF1R). These hybrid receptors are widely expressed in
Frequently Asked Questions
What is the primary biochemical classification of IGF-2?
IGF-2 is primarily classified as an insulin-like growth factor, specifically a peptide hormone belonging to the insulin family, characterized by its structural homology to insulin and IGF-1. Its peptide nature is central to its binding specificity and receptor interactions, making it a key subject in peptide biochemistry research.
How does IGF-2 typically exert its biological effects in research models?
IGF-2 primarily exerts its biological effects by binding to and activating the insulin-like growth factor 1 receptor (IGF1R), a receptor tyrosine kinase. This binding initiates a cascade of intracellular signaling events, predominantly through the PI3K/Akt and MAPK/ERK pathways, influencing cell proliferation, differentiation, and survival in various research models. It can also bind to the insulin receptor (IR) and the IGF-2/mannose-6-phosphate receptor (IGF2R/M6P-R), though the latter is generally considered a clearance receptor rather than a primary signaling receptor.
What types of research models are commonly employed to study IGF-2?
Research into IGF-2 utilizes a diverse array of models, including *in vitro* cell culture systems (e.g., various cell lines to study specific cellular processes), genetically modified *in vivo* animal models (e.g., mice, rats with gene knockouts or overexpression to investigate developmental roles and systemic effects), and organoid cultures, which provide complex three-dimensional environments for studying tissue development and function. Each model offers unique insights into different aspects of IGF-2’s biology.
What is the significance of the IGF-2/mannose-6-phosphate receptor (IGF2R/M6P-R) in research?
The IGF-2/mannose-6-phosphate receptor (IGF2R/M6P-R) is significant in IGF-2 research primarily due to its role in IGF-2 clearance and degradation. Unlike IGF1R, IGF2R is not typically considered a signaling receptor for IGF-2. Its binding to IGF-2 leads to internalization and lysosomal degradation, thereby regulating the bioavailability of IGF-2 in the extracellular environment. Research into IGF2R often focuses on its impact on IGF-2 levels and its potential as a modulator of IGF-2-mediated effects.
How is IGF-2 expression regulated in research contexts?
The regulation of IGF-2 expression is complex and a major area of research, involving genetic, epigenetic, and transcriptional mechanisms. This includes genomic imprinting, where expression is typically from the paternal allele; control by growth hormone and other endocrine factors; and regulation by various transcription factors and enhancers. Researchers often investigate differential expression patterns in specific tissues or developmental stages to understand its precise regulatory networks.
What are the key distinctions between IGF-1 and IGF-2 in research?
While both IGF-1 and IGF-2 are insulin-like growth factors, key distinctions exist in research contexts. IGF-1 is often considered the primary mediator of postnatal growth, with its production largely growth hormone-dependent. IGF-2, conversely, plays a more prominent role in fetal and placental development, with its expression patterns often under distinct regulatory control (e.g., genomic imprinting). Although both bind IGF1R, their affinities, precise tissue distributions, and roles in specific developmental and physiological processes can differ, leading to distinct research avenues.
What analytical techniques are used to quantify IGF-2 in research samples?
Quantitative analysis of IGF-2 in research samples commonly employs techniques such as enzyme-linked immunosorbent assay (ELISA), radioimmunoassay (RIA), and liquid chromatography-mass spectrometry (LC-MS). ELISA and RIA are frequently used for their sensitivity and ability to detect intact IGF-2, while LC-MS offers high specificity and the capacity for multiplexing, allowing researchers to accurately measure IGF-2 levels in various biological matrices like cell lysates, conditioned media, or animal tissue extracts.
What are some emerging research frontiers for IGF-2 investigation?
Emerging research frontiers for IGF-2 investigation include its nuanced roles in tissue regeneration, neurodevelopmental processes, and metabolic programming during early life stages. Researchers are also exploring the intricate interplay between IGF-2 and the microbiome, its involvement in epigenetic regulation in specific cellular contexts, and the potential for selective modulation of IGF-2 signaling pathways through novel peptide mimetics or antagonists in preclinical models, aiming to dissect its specific contributions to various physiological and pathophysiological processes.
Scientific References
All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.